Compared with medical treatment, percutaneous closure procedures prevent recurrent stroke

January 8, 2018, American College of Physicians

Two systematic evidence reviews and meta-analyses show that percutaneous closure procedures prevent recurrent stroke in patients with patent foramen ovale (PFO) compared with medical treatment alone. The first review was conducted by researchers from Magna Graecia University in Catanzaro, Italy and the second by researchers from the University of Tennessee, School of Medicine. Both are published in Annals of Internal Medicine.

PFO is a common congenital heart abnormality that increases the risk for cardioembolic cerebrovascular incidents, such as stroke, or (TIAs), but most PFO carriers remain asymptomatic and do not develop serious complications. However, because PFO is associated with , particularly in young patients, it has been suggested that fixing the abnormality through surgical procedure could be warranted.

Both teams of researchers reviewed 4 randomized controlled trials comparing PFO closure using a currently available device with alone to compare risks for . The studies evaluated were PC (2013), RESPECT (2013), REDUCE (2017), and CLOSE (2017). The data showed that PFO closure reduced the risk for stroke or TIA and increased the risk for peri-procedural atrial fibrillation or atrial flutter. The authors of both reviews conclude that percutaneous PFO closure is superior to medical therapy for preventing recurrent stroke or TIA, but patients should be selected carefully considering the potential risks.

According to the authors, these results demand a revision of current practice guidelines to include a positive outlook for PFO closure for prevention of recurrent cryptogenetic stroke.

Explore further: Final results from the RESPECT study reported

More information: Annals of Internal Medicine (2018). http://annals.org/aim/article/doi/10.7326/M17-3033

Annals of Internal Medicine (2018). http://annals.org/aim/article/doi/10.7326/M17-2679

Related Stories

Final results from the RESPECT study reported

November 1, 2016
Final results from the RESPECT trial found that percutaneously closing a patent foramen ovale (PFO) using the Amplatzer PFO Occluder was superior to medical management in the prevention of recurrent ischemic stroke in patients ...

When the cause of stroke is mystery, patent foramen ovale (PFO) could be the answer

October 31, 2016
A stroke occurs when a blood vessel to the brain is either blocked by a clot or bursts, preventing the brain from receiving the oxygen it needs to survive or directly damaging brain tissue.

RESPECT trial shows closing a small hole in heart may protect against recurrent stroke

September 13, 2017
A device used to close a small hole in the heart may benefit certain stroke patients by providing an extra layer of protection for those facing years of ongoing stroke risk, according to the results of a large clinical trial ...

Study shows PFO closure may be superior to medical therapy in preventing stroke

October 25, 2012
Results of a large-scale, randomized clinical trial called RESPECT revealed that patent foramen ovale (PFO) closure may be superior to medical therapy in preventing recurrent stroke, according to a presentation of findings ...

Ablation cuts risk of recurrent stroke in patients with A-fib

November 28, 2017
(HealthDay)—For patients with atrial fibrillation (AF) and prior cerebrovascular accident (CVA), ablation is associated with reduced risk of recurrent stroke, according to a study published online Nov. 13 in the Journal ...

AAN: Closure not recommended for people with heart defect and stroke

July 27, 2016
An updated recommendation from the American Academy of Neurology (AAN) states that catheter-based closure should not be routinely recommended for people who have had a stroke and also have a heart defect called a patent foramen ...

Recommended for you

Drug now in clinical trials for Parkinson's strengthens heart contractions in animals

July 20, 2018
A drug currently in clinical trials for treating symptoms of Parkinson's disease may someday have value for treating heart failure, according to results of early animal studies by Johns Hopkins Medicine researchers.

'Good cholesterol' may not always be good

July 19, 2018
Postmenopausal factors may have an impact on the heart-protective qualities of high-density lipoproteins (HDL) - also known as 'good cholesterol' - according to a study led by researchers in the University of Pittsburgh Graduate ...

Using adrenaline in cardiac arrests results in less than 1 percent more people leaving hospital alive

July 18, 2018
A clinical trial of the use of adrenaline in cardiac arrests has found that its use results in less than 1% more people leaving hospital alive—but almost doubles the risk of severe brain damage for survivors of cardiac ...

Omega 3 supplements have little or no heart or vascular health benefit: review

July 17, 2018
New evidence published today shows there is little or no effect of omega 3 supplements on our risk of experiencing heart disease, stroke or death.

Researchers discover new genes associated with heart function

July 17, 2018
A new study from an international research team, led by Dr. Yalda Jamshidi at St George's, University of London, has identified new genes associated with heart function and development.

Southern diet could be deadly for people with heart disease

July 12, 2018
People with a history of heart disease who eat a traditional Southern diet are more likely to die than those who follow a Mediterranean dietary pattern, according to new research.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.